​​Center for H​​a​​​​​​​​​rm ​
​Redu​ction Serv​ice​​s​​​​

The Maryland Department of Health ​Center for H​arm Reduction Services ​(CHRS) ​was established in 2019 to centralize harm reduction activities across the Department. The Center is housed with the Infectious Disease Prevention and Health Services Bureau in the Prevention and Health Promotion Administration. The Center oversees the Overdose Response Program, Syringe Services Program, naloxone distribution, harm reduction grants​, and various workforce development, training, and technical assistance activities.​​​​​

​​​CHRS ​Strategic Goa​​​l and​​​ V​​isi​​​​​​​on​​​​

​​​The Center's strategic goal is to​​​ reduce substance-related morbidity and mortality by optimizing services for people who use drugs. ​The Center for Harm Reduction Services envisions a Maryland where:
​​
  • People who use drugs have access to compassionate, quality care that is free from stigma;
  • Services are low-barrier, community-based, and comprehensive; and
  • Experiences of past trauma, criminal legal involvement, and racism do not determine one’s health outcomes or quality of life.​
​​​ ​

FY23 ACCES​​S ​​Ha​​rm Reduction​​ Request for Applications​

​​The SFY23 ACCESS Harm Reduction Grant Request for Applications is open for submissions until 2:00PM on April 25, 2022. 501(c)(3) nonprofits ​ may apply.

Please note: grants we be made available to Local Health Departments through a separate solicitation-- stay tuned!

This solicitation will fund direct services and c​apacity-building initiatives that use a harm reduction framework to add​ress adverse health outcomes for people who use drugs.

​​​Allowable Costs​​​​

​​Naloxone kit materials such as bags,​ face shields, & brochures
​Rapid tests for HIV, HCV, syphilis, and COVID-19
​Safer injection supplies​Fentanyl test strips
​Wound care supplies​​​Staff salary and ​training​
​Syringe disposal kiosksAnd mor​e!


Important Dates​​​

April 12, 2022, 9:30-11:00AM

Join the pre-application webinar by Google Meet​ or by phone: 1(405)-355-2356‬, PIN: ‪424 182 039‬#

2:00PM April 25, 2022

Submissions due.

SFY23 - SFY24

​The funding period will be July 1, 2022 - June 30, 2023 with optional extension period July 1, 2023 – Jun​e 30, 2024​.

Links

​​New St​atewide​​ Stan​ding ​​Order​​ for Pharmacy Dispensin​g

The statewide standing order​​ issued by Dr. Jinlene Chan, MD, MPH, Deputy Secretary for Public Health, Maryland Department of Health (MDH), allows all Maryland licensed pharm​acists to dispense naloxone, including any necessary supplies for administration, to any individual.

Pharmacists may dispense naloxone to anyone, regardless of whether the person has previously been trained under ORP or received training in opioid overdose response.

​The standing order issued June 1, 2021 is effective until June 1, 2023, at which time a new order will be issued.

​​

Download the n​aloxone standing order for pharmacy dispensing.​​

COVID-19 ​​and Harm ​​Reduction Information and R​​esources​

​​​​​​Please click here​ for COVID-19 resources and i​nformation for harm reduction programs.

Overdose​ Resp​onse Progra​​m

The Center for Harm Reduction Serv​ices authorizes government agencies and community-based organizations as Over​dose Response Programs, allowing them to provide overdose education and dispense naloxone to the community.​ Please contact mdh.naloxone@maryland.gov with any questions.

Syringe Service​s Progra​ms

The Center for Harm Reduction administers the Maryland Syringe Services Program, reviewing new applications, managing program reporting, issuing program guidance, and providing TA and support to approved programs. The Center for Harm Reduction Services also holds quarterly meetings of the Standing Advisory Committee on Opioid-Associated Disease Prevention and Outreach. These meetings are open to the public. Please contact mdh.syringeservices@maryland.gov with any questions.

CHRS Grants and Res​ourc​​es​

Through our grant programs​, the Center for Harm Reduction Services supports the local i​mplementation of harm reduction programs and ensures statewide access to resources for harm reduction activities including naloxone. ​These grants support the CHRS goals of reducing substance-related morbidity and mortality by optimizing services for people who use drugs. Please contact mdh.access@maryland.gov​ with any questions.

​ ​

​​​​Training ​and Tec​​hnica​l ​Ass​istance​

The Maryland Department of Health, Center for Harm Reduction Services partners ​with the Maryland Harm Reduction Training Institute (MaHRTI)​ to build the capacity of Maryland's harm reduction workforce to provide optimal services to people who use drugs. For more information, visit mahrti.thinkific.com​ or contact mahrti@bhsbaltimore.org. The Center also provides other workforce development and training, including the Regrounding Our Response initiative and Law Enforcement Assisted Diversion training.

Contact Us​​​

Subject:
​​Please email:​

​​​​​Naloxone and Overdose Response Progr​​​ams

mdh.naloxone@maryland.gov
​Grants, fiscal questio​ns, and resources requests
mdh.access@maryland.gov​
Syringe Services Programs​
​mdh.syringeservices@maryland.gov


​​







​​​​Center for Harm
​Reduction Services
​​​P​ag​es​​

​​​​​​​​​​​​










​​